Changjiang Pharmaceutical Group Co., Ltd.

    Changjiang Pharmaceutical Group Co., Ltd.

    SSZSE:300391
    0.19
    CNY
    0.00
    (0.00%)
    2012 Y
    2013 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    1.2
    1.36
    1.02
    0.76
    1.11
    2.64
    3.82
    2.07
    3.47
    6.74
    4.61
    3.42
    0.32
    0.31
    Basic EPS, GAAP
    0.19
    0.19
    0.12
    0.02
    0.02
    0.25
    0.44
    -1.91
    0.07
    0.14
    -0.07
    -1.73
    -1.79
    -1.69
    Free Cash Flow per Basic Share
    -0.08
    -0.2
    -0.3
    0.07
    -0.15
    0.12
    0.56
    0.05
    0.04
    0.25
    -0.34
    -0.44
    -0.23
    - -
    Dividend per Share
    0.1
    0.12
    0.07
    0.1
    0.07
    0.05
    0.09
    0.08
    0.04
    0.11
    0.16
    0.18
    0.1
    0.06
    Book Value per Share
    0.63
    0.74
    0.76
    1.1
    1.31
    1.34
    2.2
    -0.16
    -0.09
    0.05
    -0.02
    -1.75
    -3.54
    -3.87
    Tangible Book Value per Share
    0.87
    0.93
    1.37
    1.29
    1.52
    0.96
    3.37
    1.96
    1.93
    2.41
    2.7
    1.95
    -1.47
    -1.87
    Basic Weighted Avg Shares
    187
    187
    239
    251
    211
    282
    231
    350
    350
    350
    351
    350
    350
    350
    Sales/Revenue/Turnover
    225
    255
    243
    191
    235
    744
    881
    725
    1,215
    2,362
    1,615
    1,198
    112
    109
    Operating Margin (%)
    19.71
    18.51
    15.92
    -0.36
    -1.12
    11.78
    14.94
    -5.51
    7.65
    12.8
    11.39
    6.61
    -118.69
    -126.81
    Depreciation Expense
    14
    14
    15
    20
    26
    38
    43
    43
    43
    60
    115
    46
    37
    - -
    Net Income, GAAP
    35
    35
    29
    5
    4
    70
    102
    -670
    25
    49
    -23
    -606
    -628
    -592
    Effective Tax Rate (%)
    10.81
    10.34
    7.66
    - -
    - -
    2.62
    14.5
    - -
    - -
    - -
    37.94
    - -
    - -
    - -
    Profit Margin (%)
    15.75
    13.69
    11.8
    2.63
    1.8
    9.37
    11.58
    -92.33
    2.08
    2.08
    -1.44
    -50.57
    -562.56
    -545.15
    Working Capital
    81
    -14
    62
    87
    67
    -68
    417
    350
    -510
    -51
    197
    248
    -795
    -1,009
    LT Debt
    40
    20
    - -
    75
    50
    25
    - -
    - -
    345
    332
    341
    524
    446
    376
    Total Equity
    173
    198
    365
    364
    363
    934
    1,432
    752
    1,449
    1,609
    1,665
    1,017
    -421
    -563
    Return on Invested Capital (%)
    13
    11.13
    7.15
    - -
    - -
    9.29
    7.73
    - -
    - -
    - -
    4.57
    - -
    - -
    - -
    Return on Capital (%)
    18.4
    14.47
    11.78
    - -
    - -
    14.05
    16.56
    - -
    - -
    - -
    -3.25
    - -
    - -
    - -
    Return on Common Equity (%)
    33.66
    27.19
    17.89
    2.19
    1.52
    21.34
    23.08
    - -
    - -
    - -
    - -
    - -
    - -
    - -

    Capital Structure

    CNY

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    304
    304
    265
    LT Borrowings
    444
    444
    375
    LT Finance Leases
    1
    1
    1
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    350
    350
    350
    Market Capitalization
    1,766
    1,927
    1,541

    Working Capital

    CNY

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    1,129
    1,185
    1,150
    Cash, Cash Equivalents & STI
    8
    9
    10
    Accounts Receivable, Net
    980
    1,023
    991
    Inventories
    42
    47
    56
    Total Current Liabilities
    1,925
    2,045
    2,160
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    304
    304
    265
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    CNY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    8.96%
    -14.62%
    -141.42%
    Free Cash Flow
    -17.21%
    53.33%
    -48.44%
    Net Income, GAAP
    309.15%
    469.76%
    3.68%
    Sales/Revenue/Turnover
    23.27%
    2.76%
    -90.68%
    Total Cash Common Dividend
    23.4%
    31.14%
    -41.61%

    Quarterly Revenue

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    137
    339
    546
    176
    1,198
    2024
    59
    15
    27
    11
    112
    2025
    46
    25
    - -
    - -
    - -

    Quarterly Earnings Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -0.07
    - -
    - -
    - -
    -1.73
    2024
    -0.14
    - -
    - -
    - -
    -1.79
    2025
    -0.17
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    CNY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.03
    - -
    - -
    - -
    0.18
    2024
    0.03
    - -
    - -
    - -
    0.1
    2025
    0.01
    - -
    - -
    - -
    - -

    Company Description

    Company Profile APIChatGPT
    Address
    Similar Companies
    Business